GWAS for several diseases have led to the identification of a large number of associated variants in functionally plausible genes as in the case of FTO for obesity [11], SLC30A8 for type 2 diabetes [12], and APOE for Alzheimer’s disease [13]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.